Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
April 09, 2026
Taiwan says Chinese coast guard, research ships near key S. China Sea islands
Musk's SpaceX IPO jolts life back into European retail investing
Ukraine targets St. Petersburg again after Putin rejects Zelenskyy's offer for direct talks
Indonesia central bank, finance minister agree to boost asset yields to aid rupiah
Roki Sasaki’s 10 strikeouts, a harder splitter and a long-awaited breakthrough for the Dodgers
Freddie Freeman crushes a walkoff homer, lifting the Dodgers over the Angels 1-0
A comeback to savor, a finish to forget. Wemby and the Spurs let Game 2 of the NBA Finals get away